Cargando…

Nilotinib‐induced bone marrow CD34+/lin‐Ph+ cells early clearance in newly diagnosed CP‐Chronic Myeloid Leukemia: Final report of the PhilosoPhi34 study

Chronic Myeloid Leukemia is a clonal disorder characterized by the presence of the Ph‐chromosome and the BCR‐ABL tyrosine‐kinase (TK). Target‐therapy with Imatinib has greatly improved its outcome. Deeper and faster responses are reported with the second‐generation TKI Nilotinib. Sustained responses...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pungolino, Ester, D'adda, Mariella, De Canal, Gabriella, Trojani, Alessandra, Perego, Alessandra, Elena, Chiara, Lunghi, Francesca, Turrini, Mauro, Borin, Lorenza, Iurlo, Alessandra, Latargia, Maria Luisa, Carraro, Maria Cristina, Spina, Francesco, Artale, Salvatore, Anghilieri, Michela, Molteni, Alfredo, Caramella, Marianna, Baruzzo, Giacomo, Nichelatti, Michele, Di Camillo, Barbara, Cairoli, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292618/ https://www.ncbi.nlm.nih.gov/pubmed/34139044 http://dx.doi.org/10.1111/ejh.13680

Ejemplares similares

Nilotinib interferes with cell cycle, ABC transporters and JAK-STAT signaling pathway in CD34+/lin- cells of patients with chronic phase chronic myeloid leukemia after 12 months of treatment
por: Trojani, Alessandra, et al.
Publicado: (2019)

Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34(−) and immature CD34(+) cells
por: Berger, Marc G., et al.
Publicado: (2021)

Trend of circulating CD34(+) cells in patients with myelofibrosis: Association with spleen response during ruxolitinib treatment
por: Iurlo, Alessandra, et al.
Publicado: (2022)

A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis
por: Maffioli, Margherita, et al.
Publicado: (2022)

Use of generic imatinib as first-line treatment in patients with chronic myeloid leukemia (CML): the GIMS (Glivec to Imatinib Switch) study
por: Gemelli, Maria, et al.
Publicado: (2020)

Occurrence of L1M Elements in Chromosomal Rearrangements Associated to Chronic Myeloid Leukemia (CML): Insights from Patient-Specific Breakpoints Characterization
por: L’Abbate, Alberto, et al.
Publicado: (2023)

Cordycepin (3′dA) Induces Cell Death of AC133(+) Leukemia Cells via Re-Expression of WIF1 and Down-Modulation of MYC
por: Abazari, Nazanin, et al.
Publicado: (2023)

Nilotinib Enhances the Efficacy of Conventional Chemotherapeutic Drugs in CD34(+)CD38(−) Stem Cells and ABC Transporter Overexpressing Leukemia Cells
por: Wang, Fang, et al.
Publicado: (2014)

P1018: TREND OF CIRCULATING CD34+ CELLS IN MYELOFIBROSIS PATIENTS TREATED WITH RUXOLITINIB
por: Cattaneo, D., et al.
Publicado: (2022)

Imatinib and Nilotinib Inhibit Hematopoietic Progenitor Cell Growth, but Do Not Prevent Adhesion, Migration and Engraftment of Human Cord Blood CD34(+) Cells
por: Belle, Ludovic, et al.
Publicado: (2012)

Similar expression profiles in CD34(+) cells from chronic phase chronic myeloid leukemia patients with and without deep molecular responses to nilotinib
por: Patel, Ami B., et al.
Publicado: (2018)

Recurrent chronic myeloid leukemia with t (9;22;16) (q34; q11; p13) treated by nilotinib: A case report
por: Shu, Yefei, et al.
Publicado: (2018)

Prognostic Impact of Immunohistochemical p53 Expression in Bone Marrow Biopsy in Higher Risk MDS: a Pilot Study
por: Molteni, Alfredo, et al.
Publicado: (2019)

CD34(+) stem cells from umbilical cord blood
por: Pafumi, Carlo, et al.
Publicado: (2011)

Normal and intruder configurations in $^{34}$Si populated in the $\beta^-$ decay of $^{34}$Mg and $^{34}$Al
por: Lica, R., et al.
Publicado: (2019)

Properties of intruder states in $^{34}$Al and $^{34}$Si
por: Rotaru, F, et al.
Publicado: (2015)

Properties of low-lying intruder states in 34Aland 34Sipopulated in the beta-decay of 34Mg
por: Lică, R, et al.
Publicado: (2015)

Small-bowel myeloid sarcoma: Report of a case with atypical presentation
por: Girelli, Carlo M., et al.
Publicado: (2014)

A Nine-Gene Expression Signature Distinguished a Patient with Chronic Lymphocytic Leukemia Who Underwent Prolonged Periodic Fasting
por: Bossi, Luca Emanuele, et al.
Publicado: (2023)

Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trials
por: Luciano, Luigia, et al.
Publicado: (2023)

The $^{34,35}Al$ beta decay to $^{34,35}Si$
por: Nummela, S, et al.
Publicado: (1999)

Identification of a Candidate Gene Set Signature for the Risk of Progression in IgM MGUS to Smoldering/Symptomatic Waldenström Macroglobulinemia (WM) by a Comparative Transcriptome Analysis of B Cells and Plasma Cells
por: Trojani, Alessandra, et al.
Publicado: (2021)

Properties of low-lying intruder states in 34Al and 34Si sequentially populated in beta-decay of 34Mg
por: Negoita, F, et al.
Publicado: (2014)

Properties of low-lying intruder states in $^{34}$Al and $^{34}$Si sequentially populated in $\beta$-decay of $^{34}$Mg
por: Negoita, F, et al.
Publicado: (2014)

Properties of low-lying intruder states in $^{34}$Al and $^{34}$Si sequentially populated in $\beta$-decay of $^{34}$Mg
por: Negoita, F, et al.
Publicado: (2014)

Properties of low-lying intruder states in $^{34}$Al and $^{34}$Si sequentially populated in $\beta$-decay of $^{34}$Mg
por: Negoita, F, et al.
Publicado: (2011)

Fibrosarcomatous changes and expression of CD34+ and apolipoprotein-D in dermatofibrosarcoma protuberans
por: Palmerini, Emanuela, et al.
Publicado: (2012)

Announcement: ICCC34 - 34th International Conference on Coordination Chemistry
Publicado: (1999)

Comparison of Overhauser DNP at 0.34 and 3.4 T with Frémy’s Salt
por: Türke, M.-T., et al.
Publicado: (2012)

Symphonies 34-39
por: Haydn, Michael, 1737-1806
Publicado: (1996)

Geophysik, 3.4
por: Ginzburg, Vitalii Lazarevich, et al.
Publicado: (1972)

34-June 2011
Publicado: (2011)

Preparing for WA34
Publicado: (1977)

Bulletin No. 34/2006
Publicado: (2009)

CCM no. 34 extended
Publicado: (1978)

Volume 34 Index
Publicado: (2012)

T34. Submission Withdrawn
Publicado: (2018)

Italian Physicians’ Perceptions about the Role of Asciminib in Later Lines Chronic Myeloid Leukemia in Clinical Practice: A GIMEMA Survey
por: Breccia, Massimo, et al.
Publicado: (2023)

Interstitial microdeletion of the 1p34.3p34.2 region
por: Jacher, Joseph E., et al.
Publicado: (2018)

Single-Cell RNA-Sequencing: Assessment of Differential Expression Analysis Methods
por: Dal Molin, Alessandra, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cl6cf41h6251u3blqdmr3spjq1